Exploring ferroptosis induction: A promising approach to enhance OSCC treatment efficacy and overcome drug resistance

Exploring ferroptosis induction: A promising approach to enhance OSCC treatment efficacy and overcome drug resistance

Saved in:

Bibliographic Details
Main Author:	Geetha Shanmugam
Format:	Article
Language:	English
Published:	Elsevier 2024-06-01
Series:	Oral Oncology Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772906024003339
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Ferroptosis and pyroptosis are connected through autophagy: a new perspective of overcoming drug resistance
by: Peng Zhao, et al.
Published: (2025-01-01)

Combining radiation therapy with microbubbles: An emerging and promising approach to cancer treatment
by: Geetha Shanmugam
Published: (2024-06-01)

Effects of macrophages in OSCC progression
by: Xiaodan Dong, et al.
Published: (2025-01-01)

Inflammasome-targeted therapy for oral cancer: Highlighting NLRP3 inflammasome as a promising clinical therapeutic target
by: Geetha Shanmugam
Published: (2024-06-01)

Application of Nano-drug Delivery Technology in Overcoming Drug Resistance  in Lung Cancer
by: Yingchun LU, et al.
Published: (2024-11-01)

Targeting ferroptosis: a promising approach for treating lung carcinoma
by: Ziyang Wu, et al.
Published: (2025-01-01)

Redefining bladder cancer treatment: innovations in overcoming drug resistance and immune evasion
by: Peng Huang, et al.
Published: (2025-01-01)

Letter to the editor, “exploring salivary gene expression clusters: A bioinformatics approach for advanced diagnosis and prognosis in head and neck squamous cell carcinoma”
by: Geetha Shanmugam
Published: (2024-09-01)

Rethinking nutrition management in OSCC care: Beyond tube feeding
by: Nitya Krishnasamy, et al.
Published: (2024-09-01)

Strategies to Overcome Antileishmanial Drugs Unresponsiveness
by: Shyam Sundar, et al.
Published: (2014-01-01)

Molecular Mechanisms of Breast Cancer Drug Resistance and CRISPR/Cas9 Strategies to Overcome
by: Bashdar Mahmud Hussen, et al.
Published: (2024-12-01)

Hybrid computational models for integrating clinical and molecular OSCC biomarker data
by: Hema Shree Kasi Rajan, et al.
Published: (2024-06-01)

Insights into miRNA-based therapeutic strategies for oral cancer: Targeting HIF-1α to enhance patient outcomes
by: Geetha Shanmugam
Published: (2024-09-01)

Peptide–Polymer Conjugates: A Promising Therapeutic Solution for Drug-Resistant Bacteria
by: Xuqiu Shen, et al.
Published: (2022-01-01)

Targeting epithelial-mesenchymal transition signaling pathways with Dietary Phytocompounds and repurposed drug combinations for overcoming drug resistance in various cancers
by: A.N.K.V. Sravani, et al.
Published: (2025-02-01)

Advancements in targeted drug delivery: A promising approach in oral cancer treatment
by: Rajkumar Prabhakaran, et al.
Published: (2024-06-01)

Rational Design of Biocompatible Ir(III) Photosensitizer to Overcome Drug‐Resistant Cancer via Oxidative Autophagy Inhibition
by: Mingyu Park, et al.
Published: (2025-01-01)

Promising new drugs and therapeutic approaches for treatment of ovarian cancer—targeting the hallmarks of cancer
by: Julia Hillmann, et al.
Published: (2025-01-01)

Letter to the editor, “Inhibition of anti-tumour reactivity of immune cells in the salivary gland cancer: A proteomic approach.”
by: Geetha Shanmugam
Published: (2024-09-01)

EGFR-targeting RNase A-cetuximab antibody-drug conjugate induces ROS-mediated apoptosis to overcome drug resistance in KRAS mutant cancer cells
by: Bita Jafary, et al.
Published: (2025-01-01)

Harnessing programmed death-ligand 1 as a prognostic marker in OSCC: Challenges and opportunities in the era of immunotherapy
by: Madhan Krishnan, et al.
Published: (2024-09-01)

Overcoming hypoxia-induced breast cancer drug resistance: a novel strategy using hollow gold-platinum bimetallic nanoshells
by: Lian-Ying Zhang, et al.
Published: (2025-02-01)

Promising approach for composting disposable diapers enhanced by Cyanobacteria
by: D. Kusumawati, et al.
Published: (2021-07-01)

Recent advancements to enhance the therapeutic efficacy of antiepileptic drugs
by: Li Fuquan, et al.
Published: (2021-12-01)

Promising horizons in achondroplasia along with the development of new drugs
by: Keiichi Ozono, et al.
Published: (2024-07-01)

Biogenic nanoparticles as a promising drug delivery system
by: Rehab M. Abdel-Megeed
Published: (2025-06-01)

AKRs confer oligodendrocytes resistance to differentiation-stimulated ferroptosis
by: Valentina Saverio, et al.
Published: (2025-02-01)

Advancements in cellular immunotherapy: overcoming resistance in lung and colorectal cancer
by: Lijuan Qin, et al.
Published: (2025-02-01)

CHANGE OF ORGANIZATIONAL CULTURE OF THE ENTERPRISE AS OVERCOMING OF DIGITAL TRANSFORMATION RESISTANCE
by: H. Menin
Published: (2020-02-01)

The Role and Mechanisms of Antimicrobial Peptides in Overcoming Multidrug-Resistant Bacteria
by: Jinhui Yang, et al.
Published: (2024-12-01)

Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer
by: Yixiang Gu, et al.
Published: (2025-01-01)

NSUN2 lactylation drives cancer cell resistance to ferroptosis through enhancing GCLC-dependent glutathione synthesis
by: Kaifeng Niu, et al.
Published: (2025-02-01)

Dual inhibition of BET and EP300 has antitumor activity in undifferentiated pleomorphic sarcomas and synergizes with ferroptosis induction
by: Stéphanie Verbeke, et al.
Published: (2025-02-01)

Insights into the role of exosomes in oral cancer: Current challenges and future perspectives
by: Geetha Shanmugam
Published: (2024-06-01)

Understanding the oral health risks of vaping: Implications for oral cancer and periodontal disease
by: Geetha Shanmugam
Published: (2024-06-01)

Letter to the editor, “Depth-dependent PD-L1 sampling of head and neck squamous cell carcinoma (HNSCC) – Implications for PD-1/PD-L1 checkpoint inhibitor immunotherapy.”
by: Geetha Shanmugam
Published: (2024-09-01)

Letter to the editor, “Predictors of anxiety and depression in patients with oral cancer are undergoing radical resection with reconstructive surgery”
by: Geetha Shanmugam
Published: (2024-09-01)

Evaluation of exo-long noncoding RNA MALAT1 in OSCC in comparison to dysplastic and normal: A cross-sectional study
by: Ramya Sekar, et al.
Published: (2025-01-01)

Epstein-Barr virus-encoded Latent Membrane protein-1(LMP-1) as a Prognostic marker in OSCC and OPMDs
by: Ramya Selvam, et al.
Published: (2024-03-01)

MicroRNA-21 as a biomarker in terminal stage oral squamous cell carcinoma (OSCC) in the South Indian population
by: Chevuru Sai Shreya Reddy, et al.
Published: (2024-03-01)